KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) FCF Margin (2016 - 2026)

Medpace Holdings filings provide 12 years of FCF Margin readings, the most recent being 20.52% for Q1 2026.

  • On a quarterly basis, FCF Margin fell 22.0% to 20.52% in Q1 2026 year-over-year; TTM through Mar 2026 was 26.55%, a 146.0% increase, with the full-year FY2025 number at 26.95%, down 19.0% from a year prior.
  • FCF Margin hit 20.52% in Q1 2026 for Medpace Holdings, down from 26.55% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 35.69% in Q3 2025 to a low of 11.18% in Q1 2022.
  • Median FCF Margin over the past 5 years was 24.32% (2022), compared with a mean of 24.29%.
  • Biggest five-year swings in FCF Margin: tumbled -837bps in 2022 and later soared 1254bps in 2024.
  • Medpace Holdings' FCF Margin stood at 32.34% in 2022, then decreased by -9bps to 29.38% in 2023, then grew by 16bps to 34.11% in 2024, then dropped by -22bps to 26.55% in 2025, then fell by -23bps to 20.52% in 2026.
  • The last three reported values for FCF Margin were 20.52% (Q1 2026), 26.55% (Q4 2025), and 35.69% (Q3 2025) per Business Quant data.